FDA-Drug2025-12-31Class IIPROCESSING DEFECT
Merck Emend (aprepitant) oral suspension recalled for potential metal particulates
What this means
Merck has recalled a limited lot of Emend (aprepitant) 125 mg oral suspension due to the potential presence of metal particles in the product. This affects 3 single-dose kits with lot number Z014503 and expiration date 11/15/2027 distributed nationwide.
- Check if you have Emend lot Z014503 with expiration 11/15/2027
- Do not use this lot if you have it
- Contact your pharmacy or doctor for guidance on your prescription
- Call Merck at 1-800-672-6372 with questions
The agency's original wording
Hazard
Presence of particulate matter: potential presence of metal particulates in the product.
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the USA
Affected count
3 - single dose kits
Manufactured in
4633 Merck Rd W, N/A, Wilson, NC, United States
Products
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0241-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.